[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.4062/biomolther.2017.179

The Pentose Phosphate Pathway as a Potential Target for Cancer Therapy

Cho, Eunae Sandra (Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry)
Cha, Yong Hoon (Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry)
Kim, Hyun Sil (Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry)
Kim, Nam Hee (Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry)
Yook, Jong In (Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry)

Publication Information

Biomolecules & Therapeutics / v.26, no.1, 2018 , pp. 29-38 More about this Journal

Abstract

During cancer progression, cancer cells are repeatedly exposed to metabolic stress conditions in a resource-limited environment which they must escape. Increasing evidence indicates the importance of nicotinamide adenine dinucleotide phosphate (NADPH) homeostasis in the survival of cancer cells under metabolic stress conditions, such as metabolic resource limitation and therapeutic intervention. NADPH is essential for scavenging of reactive oxygen species (ROS) mainly derived from oxidative phosphorylation required for ATP generation. Thus, metabolic reprogramming of NADPH homeostasis is an important step in cancer progression as well as in combinational therapeutic approaches. In mammalian, the pentose phosphate pathway (PPP) and one-carbon metabolism are major sources of NADPH production. In this review, we focus on the importance of glucose flux control towards PPP regulated by oncogenic pathways and the potential therein for metabolic targeting as a cancer therapy. We also summarize the role of Snail (Snai1), an important regulator of the epithelial mesenchymal transition (EMT), in controlling glucose flux towards PPP and thus potentiating cancer cell survival under oxidative and metabolic stress.

Keywords

Pentose phosphate pathway; NADPH; Glucose-6-phosphate dehydrogenase; Snail; Epithelial-mesenchymal transition;

Citations & Related Records

Times Cited By KSCI : 3 (Citation Analysis)

Reference
Cited By KSCI

1	Kang, S. W., Lee, S. and Lee, E. K. (2015) ROS and energy metabolism in cancer cells: alliance for fast growth. Arch. Pharm. Res. 38, 338-345. DOI
2	Kim, N. H., Cha, Y. H., Lee, J., Lee, S. H., Yang, J. H., Yun, J. S., Cho, E. S., Zhang, X., Nam, M., Kim, N., Yuk, Y. S., Cha, S. Y., Lee, Y., Ryu, J. K., Park, S., Cheong, J. H., Kang, S. W., Kim, S. Y., Hwang, G. S., Yook, J. I. and Kim, H. S. (2017) Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress. Nat. Commun. 8, 14374. DOI
3	Kim, N. H., Kim, H. S., Li, X. Y., Lee, I., Choi, H. S., Kang, S. E., Cha, S. Y., Ryu, J. K., Yoon, D., Fearon, E. R., Rowe, R. G., Lee, S., Maher, C. A., Weiss, S. J. and Yook, J. I. (2011) A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J. Cell Biol. 195, 417-433. DOI
4	Kim, S. Y. (2015) Cancer metabolism: targeting cancer universality. Arch. Pharm. Res. 38, 299-301. DOI
5	Stanton, R. C., Seifter, J. L., Boxer, D. C., Zimmerman, E. and Cantley, L. C. (1991) Rapid release of bound glucose-6-phosphate dehydrogenase by growth factors. Correlation with increased enzymatic activity. J. Biol. Chem. 266, 12442-12448.
6	Tarin, D., Price, J. E., Kettlewell, M. G., Souter, R. G., Vass, A. C. and Crossley, B. (1984) Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res. 44, 3584-3592.
7	Tian, W. N., Braunstein, L. D., Pang, J., Stuhlmeier, K. M., Xi, Q. C., Tian, X. and Stanton, R. C. (1998) Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J. Biol. Chem. 273, 10609-10617. DOI
8	Ko, Y. H., Domingo-Vidal, M., Roche, M., Lin, Z., Whitaker-Menezes, D., Seifert, E., Capparelli, C., Tuluc, M., Birbe, R. C., Tassone, P., Curry, J. M., Navarro-Sabate, A., Manzano, A., Bartrons, R., Caro, J. and Martinez-Outschoorn, U. (2016) TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically reprograms carcinoma and stromal cells in breast cancer. J. Biol. Chem. 291, 26291-26303. DOI
9	Koppenol, W. H., Bounds, P. L. and Dang, C. V. (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11, 325-337. DOI
10	Kruiswijk, F., Labuschagne, C. F. and Vousden, K. H. (2015) p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat. Rev. Mol. Cell Biol. 16, 393-405. DOI
11	Valastyan, S. and Weinberg, R. A. (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292. DOI
12	Vander Heiden, M. G., Cantley, L. C. and Thompson, C. B. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033. DOI
13	Vander Heiden, M. G., Locasale, J. W., Swanson, K. D., Sharfi, H., Heffron, G. J., Amador-Noguez, D., Christofk, H. R., Wagner, G., Rabinowitz, J. D., Asara, J. M. and Cantley, L. C. (2010) Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329, 1492-1499.
14	Wang, H., Nicolay, B. N., Chick, J. M., Gao, X., Geng, Y., Ren, H., Gao, H., Yang, G., Williams, J. A., Suski, J. M., Keibler, M. A., Sicinska, E., Gerdemann, U., Haining, W. N., Roberts, T. M., Polyak, K., Gygi, S. P., Dyson, N. J. and Sicinski, P. (2017) The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival. Nature 546, 426-430. DOI
15	Warburg, O. (1956) On the origin of cancer cells. Science 123, 309-314. DOI
16	Ward, P. S. and Thompson, C. B. (2012) Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21, 297-308. DOI
17	Lin, R., Elf, S., Shan, C., Kang, H. B., Ji, Q., Zhou, L., Hitosugi, T., Zhang, L., Zhang, S., Seo, J. H., Xie, J., Tucker, M., Gu, T. L., Sudderth, J., Jiang, L., Mitsche, M., DeBerardinis, R. J., Wu, S., Li, Y., Mao, H., Chen, P. R., Wang, D., Chen, G. Z., Hurwitz, S. J., Lonial, S., Arellano, M. L., Khoury, H. J., Khuri, F. R., Lee, B. H., Lei, Q., Brat, D. J., Ye, K., Boggon, T. J., He, C., Kang, S., Fan, J. and Chen, J. (2015) 6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nat. Cell Biol. 17, 1484-1496. DOI
18	Li, B., Qiu, B., Lee, D. S., Walton, Z. E., Ochocki, J. D., Mathew, L. K., Mancuso, A., Gade, T. P., Keith, B., Nissim, I. and Simon, M. C. (2014) Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature 513, 251-255. DOI
19	Li, H. and Jogl, G. (2009) Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator). J. Biol. Chem. 284, 1748-1754.
20	Wong, C. W., Lee, A., Shientag, L., Yu, J., Dong, Y., Kao, G., Al-Mehdi, A. B., Bernhard, E. J. and Muschel, R. J. (2001) Apoptosis: an early event in metastatic inefficiency. Cancer Res. 61, 333-338.
21	Locasale, J. W. (2013) Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 13, 572-583. DOI
22	Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F. and Groom, A. C. (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153, 865-873. DOI
23	Mor, I., Cheung, E. C. and Vousden, K. H. (2011) Control of glycolysis through regulation of PFK1: old friends and recent additions. Cold Spring Harb. Symp. Quant. Biol. 76, 211-216.
24	Clem, B., Telang, S., Clem, A., Yalcin, A., Meier, J., Simmons, A., Rasku, M. A., Arumugam, S., Dean, W. L., Eaton, J., Lane, A., Trent, J. O. and Chesney, J. (2008) Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol. Cancer Ther. 7, 110-120. DOI
25	Yi, W., Clark, P. M., Mason, D. E., Keenan, M. C., Hill, C., Goddard, W. A., 3rd, Peters, E. C., Driggers, E. M. and Hsieh-Wilson, L. C. (2012) Phosphofructokinase 1 glycosylation regulates cell growth and metabolism. Science 337, 975-980. DOI
26	Zhang, J., Wang, J., Xing, H., Li, Q., Zhao, Q. and Li, J. (2016) Downregulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells. Mol. Cell. Biochem. 411, 331-340.
27	Chandel, N. S., Budinger, G. R., Choe, S. H. and Schumacker, P. T. (1997) Cellular respiration during hypoxia. Role of cytochrome oxidase as the oxygen sensor in hepatocytes. J. Biol. Chem. 272, 18808-18816.
28	Cheung, E. C., Ludwig, R. L. and Vousden, K. H. (2012) Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death. Proc. Natl. Acad. Sci. U.S.A. 109, 20491-20496. DOI
29	Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L. and Cantley, L. C. (2008a) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230-233.
30	Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M. and Cantley, L. C. (2008b) Pyruvate kinase M2 is a phosphotyrosinebinding protein. Nature 452, 181-186. DOI
31	Cocco, P., Carta, P., Flore, C., Congia, P., Manca, M. B., Saba, G. and Salis, S. (1996) Mortality of lead smelter workers with the glucose-6-phosphate dehydrogenase-deficient phenotype. Cancer Epidemiol. Biomarkers Prev. 5, 223-225.
32	Cocco, P., Manca, P. and Dessi, S. (1987) Preliminary results of a geographic correlation study on G6PD deficiency and cancer. Toxicol. Pathol. 15, 106-108. DOI
33	Decrock, E., Hoorelbeke, D., Ramadan, R., Delvaeye, T., De Bock, M., Wang, N., Krysko, D. V., Baatout, S., Bultynck, G., Aerts, A., Vinken, M. and Leybaert, L. (2017) Calcium, oxidative stress and connexin channels, a harmonious orchestra directing the response to radiotherapy treatment? Biochim. Biophys. Acta 1864, 1099-1120.
34	Pandolfi, P. P., Sonati, F., Rivi, R., Mason, P., Grosveld, F. and Luzzatto, L. (1995) Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 14, 5209-5215.
35	Mullarky, E., Lucki, N. C., Beheshti Zavareh, R., Anglin, J. L., Gomes, A. P., Nicolay, B. N., Wong, J. C., Christen, S., Takahashi, H., Singh, P. K., Blenis, J., Warren, J. D., Fendt, S. M., Asara, J. M., DeNicola, G. M., Lyssiotis, C. A., Lairson, L. L. and Cantley, L. C. (2016) Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proc. Natl. Acad. Sci. U.S.A. 113, 1778-1783. DOI
36	Nkhoma, E. T., Poole, C., Vannappagari, V., Hall, S. A. and Beutler, E. (2009) The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol. Dis. 42, 267-278. DOI
37	Nogueira, V. and Hay, N. (2013) Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin. Cancer Res. 19, 4309-4314. DOI
38	Pacold, M. E., Brimacombe, K. R., Chan, S. H., Rohde, J. M., Lewis, C. A., Swier, L. J., Possemato, R., Chen, W. W., Sullivan, L. B., Fiske, B. P., Cho, S., Freinkman, E., Birsoy, K., Abu-Remaileh, M., Shaul, Y. D., Liu, C. M., Zhou, M., Koh, M. J., Chung, H., Davidson, S. M., Luengo, A., Wang, A. Q., Xu, X., Yasgar, A., Liu, L., Rai, G., Westover, K. D., Vander Heiden, M. G., Shen, M., Gray, N. S., Boxer, M. B. and Sabatini, D. M. (2016) A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat. Chem. Biol. 12, 452-458. DOI
39	Paglialunga, F., Fico, A., Iaccarino, I., Notaro, R., Luzzatto, L., Martini, G. and Filosa, S. (2004) G6PD is indispensable for erythropoiesis after the embryonic-adult hemoglobin switch. Blood 104, 3148-3152.
40	Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J.-K., Shen, M., Bellinger, G., Sasaki, A. T., Locasale, J. W., Auld, D. S., Thomas, C. J., Vander Heiden, M. G. and Cantley, L. C. (2011) Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334, 1278-1283. DOI
41	Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N., Nakano, K., Bartrons, R., Gottlieb, E. and Vousden, K. H. (2006) TIGAR, a p53- inducible regulator of glycolysis and apoptosis. Cell 126, 107-120. DOI
42	Berg, J. M., Tymoczko, J. L. and Stryer, L. (2010) Biochemistry. W. H. Freeman, New York.
43	Bokun, R., Bakotin, J. and Milasinovic, D. (1987) Semiquantitative cytochemical estimation of glucose-6-phosphate dehydrogenase activity in benign diseases and carcinoma of the breast. Acta Cytol. 31, 249-252.
44	Bouzier-Sore, A. K. and Bolanos, J. P. (2015) Uncertainties in pentosephosphate pathway flux assessment underestimate its contribution to neuronal glucose consumption: relevance for neurodegeneration and aging. Front. Aging Neurosci. 7, 89.
45	Cabezas, H., Raposo, R. R. and Melendez-Hevia, E. (1999) Activity and metabolic roles of the pentose phosphate cycle in several rat tissues. Mol. Cell. Biochem. 201, 57-63. DOI
46	Carson, P. E., Flanagan, C. L., Ickes, C. E. and Alving, A. S. (1956) Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 124, 484-485.
47	Cha, Y. H., Yook, J. I., Kim, H. S. and Kim, N. H. (2015) Catabolic metabolism during cancer EMT. Arch. Pharm. Res. 38, 313-320. DOI
48	Chambers, A. F., Groom, A. C. and MacDonald, I. C. (2002) Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572. DOI
49	Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., Joshua, B., Kaplan, M. J., Wapnir, I., Dirbas, F. M., Somlo, G., Garberoglio, C., Paz, B., Shen, J., Lau, S. K., Quake, S. R., Brown, J. M., Weissman, I. L. and Clarke, M. F. (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780-783.
50	Aktipis, C. A., Boddy, A. M., Gatenby, R. A., Brown, J. S. and Maley, C. C. (2013) Life history trade-offs in cancer evolution. Nat. Rev. Cancer 13, 883-892. DOI
51	Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T. W., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., Lorkiewicz, P., St Clair, D., Hung, M. C., Evers, B. M. and Zhou, B. P. (2013) Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell 23, 316-331. DOI
52	Dore, M. P., Davoli, A., Longo, N., Marras, G. and Pes, G. M. (2016) Glucose-6-phosphate dehydrogenase deficiency and risk of colorectal cancer in Northern Sardinia: A retrospective observational study. Medicine (Baltimore) 95, e5254. DOI
53	Du, W., Jiang, P., Mancuso, A., Stonestrom, A., Brewer, M. D., Minn, A. J., Mak, T. W., Wu, M. and Yang, X. (2013) TAp73 enhances the pentose phosphate pathway and supports cell proliferation. Nat. Cell Biol. 15, 991-1000. DOI
54	Fan, J., Ye, J., Kamphorst, J. J., Shlomi, T., Thompson, C. B. and Rabinowitz, J. D. (2014) Quantitative flux analysis reveals folatedependent NADPH production. Nature 510, 298-302. DOI
55	Finkel, T. and Holbrook, N. J. (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247. DOI
56	Gordon, G., Mackow, M. C. and Levy, H. R. (1995) On the mechanism of interaction of steroids with human glucose 6-phosphate dehydrogenase. Arch. Biochem. Biophys. 318, 25-29. DOI
57	Riganti, C., Gazzano, E., Polimeni, M., Aldieri, E. and Ghigo, D. (2012) The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate. Free Radic. Biol. Med. 53, 421-436. DOI
58	Preuss, J., Richardson, A. D., Pinkerton, A., Hedrick, M., Sergienko, E., Rahlfs, S., Becker, K. and Bode, L. (2013) Identification and characterization of novel human glucose-6-phosphate dehydrogenase inhibitors. J. Biomol. Screen. 18, 286-297. DOI
59	Ramanathan, B., Jan, K. Y., Chen, C. H., Hour, T. C., Yu, H. J. and Pu, Y. S. (2005) Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res. 65, 8455-8460. DOI
60	Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M. and Yang, X. (2011) p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat. Cell Biol. 13, 310-316. DOI
61	Ros, S., Santos, C. R., Moco, S., Baenke, F., Kelly, G., Howell, M., Zamboni, N. and Schulze, A. (2012) Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. Cancer Discov. 2, 328-343.
62	Ros, S. and Schulze, A. (2013) Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism. Cancer Metab. 1, 8. DOI
63	Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P. and Brugge, J. S. (2009) Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461, 109-113. DOI
64	Singh, S., An, A. and Srivastava, P. K. (2012) Regulation and properties of glucose-6-phosphate dehydrogenase: a review. Int. J. Plant Physiol. Biochem. 4, 1-19.
65	Stanton, R. C. (2012) Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64, 362-369. DOI
66	Patra, K. C. and Hay, N. (2014) The pentose phosphate pathway and cancer. Trends Biochem. Sci. 39, 347-354. DOI

1	(2018) Biomolecules & Therapeutics Cancer Metabolism: a Hope for Curing Cancer / 26 (1) , 1
9	(2018) Journal of Biochemical and Molecular Toxicology -benzoylindoles as inhibitors of rat erythrocyte glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase / 32 (9) , e22193
1	(2018) Scientific Reports The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer / 8 (1)
15821838	(2019) Journal of Cellular and Molecular Medicine Nrf2 promotes breast cancer cell migration via up-regulation of G6PD/HIF-1α/Notch1 axis / (15821838)
41	(2018) Journal of agricultural and food chemistry Targeting Tumor Metabolism with Plant-Derived Natural Products: Emerging Trends in Cancer Therapy / 66 (41) , 10663
None	(2018) Oxidative medicine and cellular longevity Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype / 2018 (None) , 1027453
None	(2018) Frontiers in cell and developmental biology The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor Microenvironment / 6 (None) , 168
None	(2018) BioMed research international Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach / 2019 (None) , 1
None	(2019) Frontiers in immunology Metabolism and Autoimmune Responses: The microRNA Connection / 10 (None) , 1969
4	(2020) Current pharmaceutical design Exploring Dysregulated Signaling Pathways in Cancer / 26 (4) , 429
None	(2020) Frontiers in oncology Metabolic Adaptations in Cancer Stem Cells / 10 (None) , 1010
5	(2018) Antioxidants & redox signaling MicroRNA Targeting Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Cancer / 32 (5) , 267
2	(2018) Journal of proteome research Serum Metabolomics Reveals Personalized Metabolic Patterns for Macular Neovascular Disease Patient Stratification / 19 (2) , 699
None	(2020) Frontiers in pharmacology Metabolomic Analysis Identifies Glycometabolism Pathways as Potential Targets of Qianggan Extract in Hyperglycemia Rats / 11 (None) , 671
2	(2018) Cell proliferation Non‐enzymatic reaction of carnosine and glyceraldehyde‐3‐phosphate accompanies metabolic changes of the pentose phosphate pathway / 53 (2) , e12702
3	(2020) International journal of molecular sciences The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance / 21 (3) , 937
4	(2018) Agronomy Effects of Exogenous Spermidine on Root Metabolism of Cucumber Seedlings under Salt Stress by GC-MS / 10 (4) , 459
5	(2018) Oncogenesis <I>COX6B2</I> drives metabolic reprogramming toward oxidative phosphorylation to promote metastasis in pancreatic ductal cancer cells / 9 (5) , 51
4	(2020) BioFactors 6‐Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance / 46 (4) , 550
7	(2018) Life science alliance Snail augments fatty acid oxidation by suppression of mitochondrial ACC2 during cancer progression / 3 (7) , e202000683
14	(2020) The Analyst : An International Journal of Analytical and Bioanalytical Science Comparison of standard and HD FT-IR with multimodal CARS/TPEF/SHG/FLIMS imaging in the detection of the early stage of pulmonary metastasis of murine breast cancer / 145 (14) , 4982
8	(2020) Antioxidants & redox signaling Modulating Oxidant Levels to Promote Healthy Aging / 33 (8) , 570
10	(2018) Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine The emerging role of targeting cancer metabolism for cancer therapy / 42 (10) , 101042832096528
20	(2018) Green chemistry : an international journal and green chemistry resource : GC Recent advances in light-driven C-H bond activation and building C-C bonds with CO<SUB>2</SUB>as a feedstock for carbon capture and utilization technology / 22 (20) , 6682
22	(2018) Aging Establishing and validating a pathway prognostic signature in pancreatic cancer based on miRNA and mRNA sets using GSVA / 12 (22) , 22840
1	(2021) Journal of cellular physiology Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration / 236 (1) , 27
None	(2021) Technology in cancer research & treatment Extracellular Vesicles in Cancer Metabolism: Implications for Cancer Diagnosis and Treatment / 20 (None) , 153303382110378
4	(2018) The FEBS journal The structure of a novel membrane‐associated 6‐phosphogluconate dehydrogenase from <I>Gluconacetobacter diazotrophicus</I> (<I>Gd</I>6PGD) reveals a subfamily of short‐chain 6PGDs / 288 (4) , 1286
None	(2018) Frontiers in oncology Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming / 11 (None) , 626577
14	(2021) Oncogene c-Src facilitates tumorigenesis by phosphorylating and activating G6PD / 40 (14) , 2567
5	(2018) Cells Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation / 10 (5) , 1056
5	(2018) Nutrients Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction / 13 (5) , 1637
6	(2018) Biomedicines The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH Oxidases / 9 (6) , 687
14	(2018) International journal of molecular sciences TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Is Upregulated in Lymphocytes Stimulated with Concanavalin A / 22 (14) , 7436
8	(2021) Journal of cellular physiology Signaling, metabolism, and cancer: An important relationship for therapeutic intervention / 236 (8) , 5512
10	(2018) Cancer Science Evi1 upregulates Fbp1 and supports progression of acute myeloid leukemia through pentose phosphate pathway activation / 112 (10) , 4112
1	(2018) npj biofilms and microbiomes Metabolic plasticity enables lifestyle transitions of Porphyromonas gingivalis / 7 (1) , 46
1	(2018) Scientific reports A pan-cancer transcriptomic study showing tumor specific alterations in central metabolism / 11 (1) , 13637
1	(2018) Molecular biomedicine Cancer metabolism and intervention therapy / 2 (1) , 5
5	(2018) Chemotherapy The Pentose Phosphate Pathway in Cancer: Regulation and Therapeutic Opportunities / 66 (5) , 179